Signaling pathways
-
BA6812 VQW-765Summary: VQW-765 (AQW-051) is a selective, orally active alpha-7 nicotinic acetylcholine receptor agonist. -
BA6813 BNC210Summary: BNC210 (H-Ile-Trp-OH) is an orally effective, negative alteration modulator (NAM) without significant side effects. -
BA6814 CP-601927Summary: CP-601927 is a selective partial agonist. -
BA6815 NeloniclineSummary: Nelonicline (ABT-126) is a potent -
BA6816 bPiDISummary: bPiDI is a novel nicotinic receptor antagonist. -
BA6817 BNC375Summary: BNC375 is a potent, orally active, selective type I orthosteric modulator. -
BA6818 SUVN-911Summary: SUVN-911 is a potent and selective, brain permeable and orally bioactive neuronal nicotinic acetylcholine α4β2 receptor antagonist. -
BA6819 CP-601932Summary: CP-601932 ((1S,5R)-CP-601927) is a high affinity partial agonist. -
BA4722 BET-IN-1Summary: BET-IN-1 is a potent inhibitor. -
BA4723 QCA570Summary: QCA570 is a PROTAC linked by ligand and ligand.

